Clarke Elizabeth V, Tenner Andrea J
Department of Molecular Biology and Biochemistry and Institute for Immunology, University of California, Irvine, California, USA
Department of Molecular Biology and Biochemistry and Institute for Immunology, University of California, Irvine, California, USA.
J Leukoc Biol. 2014 Nov;96(5):745-56. doi: 10.1189/jlb.3MR0214-109R. Epub 2014 Sep 10.
The complement system is an ancient and critical effector mechanism of the innate immune system as it senses, kills, and clears infectious and/or dangerous particles and alerts the immune system to the presence of the infection and/or danger. Interestingly, an increasing number of reports have demonstrated a clear role for complement in the adaptive immune system as well. Of note, a number of recent studies have identified previously unknown roles for complement proteins, receptors, and regulators in T cell function. Here, we will review recent data demonstrating the influence of complement proteins C1q, C3b/iC3b, C3a (and C3aR), and C5a (and C5aR) and complement regulators DAF (CD55) and CD46 (MCP) on T cell function during homeostasis and disease. Although new concepts are beginning to emerge in the field of complement regulation of T cell function, future experiments should focus on whether complement is interacting directly with the T cell or is having an indirect effect on T cell function via APCs, the cytokine milieu, or downstream complement activation products. Importantly, the identification of the pivotal molecular pathways in the human systems will be beneficial in the translation of concepts derived from model systems to therapeutic targeting for treatment of human disorders.
补体系统是固有免疫系统中一种古老且关键的效应机制,它能够感知、杀伤并清除感染性和/或危险颗粒,同时向免疫系统警示感染和/或危险的存在。有趣的是,越来越多的报告表明补体在适应性免疫系统中也发挥着明确作用。值得注意的是,最近的一些研究发现了补体蛋白、受体和调节因子在T细胞功能中前所未知的作用。在此,我们将回顾近期的数据,这些数据展示了补体蛋白C1q、C3b/iC3b、C3a(及C3aR)和C5a(及C5aR)以及补体调节因子衰变加速因子(DAF,CD55)和CD46(膜辅蛋白,MCP)在稳态和疾病过程中对T细胞功能的影响。尽管在补体对T细胞功能的调节领域开始出现一些新的概念,但未来的实验应聚焦于补体是直接与T细胞相互作用,还是通过抗原呈递细胞(APC)、细胞因子环境或下游补体激活产物对T细胞功能产生间接影响。重要的是,确定人类系统中的关键分子途径将有助于将源自模型系统的概念转化为针对人类疾病治疗的靶向治疗。